- Home
- CUE vs SRFM Comparison
CUE vs SRFM Comparison
Compare CUE & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- SRFM
- Stock Information
- Founded
- CUE 2014
- SRFM 2011
- Country
- CUE United States
- SRFM United States
- Employees
- CUE N/A
- SRFM N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- SRFM Transportation Services
- Sector
- CUE Health Care
- SRFM Consumer Discretionary
- Exchange
- CUE Nasdaq
- SRFM Nasdaq
- Market Cap
- CUE 60.6M
- SRFM 58.2M
- IPO Year
- CUE 2018
- SRFM 2023
- Fundamental
- Price
- CUE $0.92
- SRFM $3.33
- Analyst Decision
- CUE Strong Buy
- SRFM Buy
- Analyst Count
- CUE 4
- SRFM 3
- Target Price
- CUE $4.75
- SRFM $6.18
- AVG Volume (30 Days)
- CUE 151.6K
- SRFM 233.6K
- Earning Date
- CUE 05-08-2025
- SRFM 03-18-2025
- Dividend Yield
- CUE N/A
- SRFM N/A
- EPS Growth
- CUE N/A
- SRFM N/A
- EPS
- CUE N/A
- SRFM N/A
- Revenue
- CUE $9,532,000.00
- SRFM $119,425,000.00
- Revenue This Year
- CUE $73.11
- SRFM $51.22
- Revenue Next Year
- CUE $11.02
- SRFM $43.89
- P/E Ratio
- CUE N/A
- SRFM N/A
- Revenue Growth
- CUE 149.53
- SRFM 97.38
- 52 Week Low
- CUE $0.45
- SRFM $0.90
- 52 Week High
- CUE $2.26
- SRFM $6.72
- Technical
- Relative Strength Index (RSI)
- CUE 33.15
- SRFM 42.38
- Support Level
- CUE $0.95
- SRFM $3.53
- Resistance Level
- CUE $1.03
- SRFM $4.14
- Average True Range (ATR)
- CUE 0.08
- SRFM 0.41
- MACD
- CUE 0.01
- SRFM -0.02
- Stochastic Oscillator
- CUE 3.85
- SRFM 6.58
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.